À¶Ý®ÊÓÆµ

Three Imperial researchers appointed to prestigious national research position

Staff and guests enjoy the 10th Anniversary of the Research Fellowship at Imperial , held in the Queen's Tower Rooms at Imperial College, 2nd July 2019Photography by Fergus BurnettAccreditation required with all use - 'fergusburnett.com

 

Three Imperial researchers have been appointed as   by the National Institute for Health and Care Research (À¶Ý®ÊÓÆµ). Professor Chris Millet is one of 39 researchers in England newly appointed as an À¶Ý®ÊÓÆµ Senior Investigator, recognising his expertise in public health and environmental policy evaluation. Professor Waljit Dhillo and Professor Azeem Majeed have been reappointed as Senior Investigators, recognising their significant contributions to research focusing on the hormonal control of reproductive function and primary care and public health research, respectively.

Professor Millet has published studies on a variety of topics, with a particular interest in health inequality impacts. This includes a focus on evaluating dual benefit strategies to prevent non-communicable diseases and limit environmental degradation in middle-income country settings. Professor Millet is lead investigator at Imperial College London for the À¶Ý®ÊÓÆµ School of Public Health Research and Co-Principal Investigator for an À¶Ý®ÊÓÆµ Global Health Research Centre on Non-Communicable Diseases and Environmental Change in Bangladesh, India and Indonesia.

Professor Dhillo, a consultant endocrinologist, also leads research in the division of medicine and integrated care at the Trust and is a Professor of Endocrinology & Metabolism at Imperial College London. He holds several key research leadership roles, including dean of the À¶Ý®ÊÓÆµ Academy and À¶Ý®ÊÓÆµ scientific director for research capacity and capabilities. Professor Dhillo also co-leads the Metabolic and Endocrine theme of the À¶Ý®ÊÓÆµ À¶Ý®ÊÓÆµ.

Professor Dhillo’s pioneering work on neurokinin B has identified a new treatment for menopause, while his studies on a newly identified hormone, known as kisspeptin, have opened new avenues for potential treatments for infertility.

Professor Majeed, an honorary consultant in public health at the Trust and head of the department of primary care & public health at Imperial College London, is also a Fellow of the Academy of Medical Sciences. He also holds an international role in public health and primary care through a position with the World Health Organization (WHO) Collaborating Centre for Public Health Education and Training at Imperial College London and is a part-time GP in Clapham, London.

Commenting on his appointment, Professor Dhillo said: “I am thrilled to have been appointed as an À¶Ý®ÊÓÆµ Senior Investigator but the award is a reflection of the brilliant team I work with who deliver our translational research.â€

Professor Majeed is one of the highest cited primary care researchers globally. His work focuses on chronic disease management, health policy and the delivery of healthcare, including the use of data for policy, planning and research, developing innovative methodologies for primary care and use of new technology. His work has influenced key policy areas such as disease prevention, health surveillance, and NHS workforce development. His expertise in clinical medicine and public health helped promote positive public health messages during the COVID-19 pandemic.

Professor Majeed said: “I’m honoured to be appointed as an À¶Ý®ÊÓÆµ Senior Investigator. This recognition reflects the essential role of primary care and public health research in improving population health and reducing health inequalities.”

The À¶Ý®ÊÓÆµ Senior Investigator scheme has long been recognised as a mark of distinction for leading researchers in health and care. Senior Investigators are outstanding research leaders in health and care, recognised for their significant contributions to the À¶Ý®ÊÓÆµ and the wider research landscape, influencing policy and providing mentorship to early-career researchers, as well as driving innovative research that improves health.

À¶Ý®ÊÓÆµ Senior Investigators serve on À¶Ý®ÊÓÆµ committees and boards, as À¶Ý®ÊÓÆµ ambassadors, demonstrate research excellence, contribute to national growth, and champion the involvement of patients and communities in research.

Professor Mark Thursz, director of À¶Ý®ÊÓÆµ Imperial BRC, said: “I want to congratulate Christopher, Waljit and Azeem on their appointments as Senior Investigators. Their appointments are a testament to their expertise and leadership in public health, endocrinology and metabolism and primary care, and I am pleased that they have been recognised by the À¶Ý®ÊÓÆµ.

“Our work plays a key role in helping us solve some of the biggest health challenges and advancing the field of translational medicine, all for the benefit of patients and populations in North West London and beyond. I am confident that Christopher, Waljit and Azeem will make valuable contributions as Senior Investigators and be fantastic advocates for our work and mission to transform patient care and public health.â€

Professor Bob Klaber, director of strategy, research and innovation, said: “Professor Dhillo and Professor Majeed’s appointments as À¶Ý®ÊÓÆµ Senior Investigators are a testament to their dedication and significant impact in their respective fields. Both of their work not only enhances our scientific knowledge but also translates into tangible benefits for patients, making them very deserving recipients of this prestigious recognition.â€

People
  • Professor Waljit Dhillo
    Professor Waljit Dhillo
    Theme Lead & À¶Ý®ÊÓÆµ Imperial BRC Training Lead
  • Professor Azeem Majeed
    Professor Azeem Majeed
    Professor of Primary Care